Goa KL, Sorkin EM. Rujan 1993. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Drugs. 46 (3): 409–427. doi:10.2165/00003495-199346030-00007. PMID7693432
Wijemanne S, Jankovic J. Lipanj 2015. Restless legs syndrome: clinical presentation diagnosis and treatment. Sleep Medicine. 16 (6): 678–90. doi:10.1016/j.sleep.2015.03.002. PMID25979181
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T. Rujan 2010. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology. 17 (9): 1113–e88. doi:10.1111/j.1468-1331.2010.02999.x. PMID20402746
Calandre EP, Rico-Villademoros F, Slim M. Studeni 2016. 2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Review of Neurotherapeutics. 16 (11): 1263–1277. doi:10.1080/14737175.2016.1202764. PMID27345098
Goa KL, Sorkin EM. Rujan 1993. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Drugs. 46 (3): 409–427. doi:10.2165/00003495-199346030-00007. PMID7693432
Wijemanne S, Jankovic J. Lipanj 2015. Restless legs syndrome: clinical presentation diagnosis and treatment. Sleep Medicine. 16 (6): 678–90. doi:10.1016/j.sleep.2015.03.002. PMID25979181
Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T. Rujan 2010. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology. 17 (9): 1113–e88. doi:10.1111/j.1468-1331.2010.02999.x. PMID20402746
Calandre EP, Rico-Villademoros F, Slim M. Studeni 2016. 2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Review of Neurotherapeutics. 16 (11): 1263–1277. doi:10.1080/14737175.2016.1202764. PMID27345098